Aclaris TherapeuticsACRS
13F holders, Q3 2024 (September 30)81holders −17
8new positions
25sold out
5famous investors
$1.15avg. 13F price*
At the end of Q3 2024, 81 institutions reported holding Aclaris Therapeutics Inc. (ACRS) in their 13F filings, down 17 from Q2 2024. 8 opened new positions and 25 sold out. The largest holders were BML Capital Management, LLC ($16.4M), Vanguard Group Inc. ($5.4M) and D. E. Shaw & Co. ($3.9M). 5 famous investors held it, including David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Aclaris Therapeutics Inc.
- CUSIP
- 00461U105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $1.4M |
| Exits | 25 | $3.0M |
All 13F filers, Q2 2024 → Q3 2024: 4,732,585 shares bought and 6,369,674 shares sold, net −1,637,089 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 81 holders
| BML Capital Management, LLC | 9.64% | Add +9.7% | 14,250,000 | $16.4M |
| Vanguard Group Inc. | 0.00% | Reduce -0.0% | 4,685,498 | $5.4M |
| D. E. Shaw & Co. | 0.01% | Add +1.6% | 3,371,849 | $3.9M |
| Millennium Management | 0.00% | Reduce -9.9% | 3,005,598 | $3.5M |
| Rock Springs Capital Management LP | 0.10% | No change | 2,753,495 | $3.2M |
| Stonepine Capital Management, LLC | 1.79% | Add +27.6% | 2,458,873 | $2.8M |
| Acadian Asset Management LLC | 0.01% | Add +8.6% | 2,078,287 | $2.4M |
| Trium Capital LLP | 1.01% | Add +1.1% | 1,912,990 | $2.2M |
| BlackRock, Inc. | 0.00% | — | 1,711,797 | $2.0M |
| Renaissance Technologies | 0.00% | Add +48.6% | 1,370,700 | $1.6M |
| Two Sigma Advisers, LP | 0.00% | Reduce -9.4% | 1,301,500 | $1.5M |
| Aldebaran Capital, LLC | 1.10% | Add +21.6% | 1,043,152 | $1.2M |
| Deutsche Bank AG | 0.00% | No change | 923,313 | $1.1M |
| Jacobs Levy Equity Management, Inc. | 0.00% | New | 915,509 | $1.1M |
| Two Sigma Investments, LP | 0.00% | Reduce -18.4% | 907,916 | $1.0M |
| Geode Capital Management, LLC | 0.00% | Add +9.3% | 846,446 | $974K |
| Samsara Biocapital, LLC | 0.15% | No change | 696,171 | $801K |
| Acuitas Investments, LLC | 0.30% | Add +24.6% | 578,139 | $665K |
| Palo Alto Investors LP | 0.09% | No change | 569,832 | $655K |
| FMR LLC | 0.00% | Reduce -20.8% | 545,972 | $628K |
| Morgan Stanley | 0.00% | Add +158.0% | 480,773 | $553K |
| Aisling Capital Management LP | 0.19% | No change | 434,455 | $500K |
| Citadel Advisors | 0.00% | Reduce -58.4% | 364,567 | $419K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +187.6% | 332,406 | $382K |
| HighTower Advisors, LLC | 0.00% | Reduce -2.2% | 305,814 | $352K |
| Goldman Sachs Group Inc. | 0.00% | Reduce -67.1% | 301,556 | $347K |
| Qube Research & Technologies Ltd | 0.00% | Reduce -68.9% | 292,845 | $337K |
| Frazier Life Sciences Management, L.P. | 0.01% | No change | 264,377 | $304K |
| Gsa Capital Partners LLP | 0.02% | Reduce -24.3% | 255,032 | $293K |
| Bridgeway Capital Management, LLC | 0.01% | Add +32.1% | 199,119 | $229K |
| State Street Corp. | 0.00% | Reduce -4.0% | 188,721 | $217K |
| Assenagon Asset Management S.A. | 0.00% | New | 185,777 | $214K |
| Squarepoint Ops LLC | 0.00% | Add +48.5% | 140,580 | $162K |
| T. Rowe Price Associates Inc. | 0.00% | No change | 139,400 | $161K |
| Northern Trust Corp. | 0.00% | Reduce -75.6% | 127,225 | $146K |
| ADAR1 Capital Management, LLC | 0.02% | New | 90,000 | $104K |
| Marquette Asset Management, LLC | 0.02% | No change | 83,979 | $97K |
| Jane Street Group, LLC | 0.00% | Reduce -75.3% | 82,727 | $95K |
| Dimensional Fund Advisors LP | 0.00% | Add +0.1% | 76,810 | $88K |
| Susquehanna International Group, LLP | 0.00% | Reduce -69.8% | 62,408 | $72K |
| BBR Partners, LLC | 0.01% | No change | 60,000 | $69K |
| Point72 Asia (Singapore) Pte. Ltd. | 0.01% | Reduce -51.8% | 52,052 | $60K |
| Mariner, LLC | 0.00% | Add +14.0% | 48,101 | $55K |
| Cambridge Investment Research Advisors, Inc. | 0.00% | No change | 41,873 | $48K |
| Engineers Gate Manager LP | 0.00% | Reduce -35.9% | 38,794 | $45K |
| Tudor Investment Corporation | 0.00% | No change | 33,183 | $38K |
| UBS Group AG | 0.00% | Reduce -5.7% | 31,852 | $37K |
| Shay Capital LLC | 0.01% | New | 27,000 | $31K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +9.2% | 21,909 | $25K |
| Barclays PLC | 0.00% | Reduce -49.3% | 20,393 | $23K |
| Vontobel Holding Ltd. | 0.00% | No change | 20,000 | $23K |
| Algert Global LLC | 0.00% | Add +67.8% | 19,770 | $23K |
| AJOVista, LLC | 0.09% | New | 17,455 | $20K |
| Marex Group Ltd | 0.00% | No change | 14,400 | $17K |
| Catalyst Funds Management Pty Ltd | 0.00% | No change | 14,000 | $16K |
| Federated Hermes, Inc. | 0.00% | Add +44.6% | 13,798 | $16K |
| China Universal Asset Management Co., Ltd. | 0.00% | Add +63.9% | 13,722 | $16K |
| Neuberger Berman Group LLC | 0.00% | No change | 12,656 | $15K |
| Jefferies Financial Group Inc. | 0.00% | No change | 11,500 | $13K |
| Two Sigma Securities, LLC | 0.00% | New | 10,740 | $12K |
| Bank of America Corp. | 0.00% | Add +34.8% | 8,757 | $10K |
| JPMorgan Chase & Co. | 0.00% | Reduce -4.8% | 8,476 | $10K |
| Cubist Systematic Strategies, LLC | 0.00% | Reduce -84.4% | 6,971 | $8K |
| Wells Fargo & Company | 0.00% | No change | 4,590 | $5K |
| BNP Paribas Financial Markets | 0.00% | Reduce -3.9% | 3,268 | $4K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -22.1% | 2,765 | $3K |
| Mirae Asset Global Investments Co., Ltd. | 0.00% | Add +21.2% | 2,580 | $3K |
| Citigroup Inc. | 0.00% | Reduce -84.5% | 2,087 | $2K |
| Osaic Holdings, Inc. | 0.00% | New | 1,732 | $2K |
| Arax Advisory Partners | 0.00% | No change | 1,632 | $2K |
| Halpern Financial, Inc. | 0.00% | No change | 1,500 | $2K |
| Capital Advisors, Ltd. LLC | 0.00% | No change | 454 | $1K |
| Simplex Trading, LLC | 0.00% | Reduce -89.3% | 1,085 | $1K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 500 | $575 |
| Nisa Investment Advisors, LLC | 0.00% | Reduce -39.7% | 318 | $366 |
| Truvestments Capital LLC | 0.00% | New | 150 | $173 |
| Farther Finance Advisors, LLC | 0.00% | No change | 99 | $114 |
| Point72 (DIFC) Ltd | 0.00% | Reduce -99.5% | 92 | $106 |
| Royal Bank of Canada | 0.00% | Reduce -98.6% | 58 | $0 |
| Daiwa Securities Group Inc. | 0.00% | No change | 248 | $0 |
| Cwm, LLC | 0.00% | Reduce -99.6% | 1 | $0 |
"% of holder's portfolio" is ACRS's weight in each manager's 13F, not the share of Aclaris Therapeutics Inc. the manager owns.